Clinical Trial Update: Intra-arterial Gemcitabine vs. IV Gemcitabine and Nab-Paclitaxel Following Radiotherapy for LAPC [Phase 3]

View source ↗

Summary

Phase 3 trial assessing intra-arterial gemcitabine versus intravenous gemcitabine with nab-paclitaxel following radiotherapy in locally advanced pancreatic canc…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Pancreatic Cancer

Drugs mentioned

• Gemcitabine (Gemcitabine)
• Nab-paclitaxel (paclitaxel protein-bound)

Snippet

Sponsor: RenovoRx | Conditions: Locally Advanced Pancreatic Cancer | Phase 3 | Status: RECRUITING